Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

Measurable residual disease (MRD) quantified by multiparameter flow cytometry (MFC) is a strong and independent prognostic factor in acute myeloid leukemia (AML). However, several technical factors may affect the final read-out of the assay. Experts from the MRD Working Party of the European Leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tettero, Jesse M., Freeman, Sylvie, Buecklein, Veit, Venditti, Adriano, Maurillo, Luca, Kern, Wolfgang, Walter, Roland B., Wood, Brent L., Roumier, Christophe, Philippé, Jan, Denys, Barbara, Jorgensen, Jeffrey L., Bene, Marie C., Lacombe, Francis, Plesa, Adriana, Guzman, Monica L., Wierzbowska, Agnieszka, Czyz, Anna, Ngai, Lok Lam, Schwarzer, Adrian, Bachas, Costa, Cloos, Jacqueline, Subklewe, Marion, Fuering-Buske, Michaela, Buccisano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Guideline Article - Evidence based
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701786/
https://www.ncbi.nlm.nih.gov/pubmed/34964040
http://dx.doi.org/10.1097/HS9.0000000000000676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701786/
https://www.ncbi.nlm.nih.gov/pubmed/34964040
http://dx.doi.org/10.1097/HS9.0000000000000676

Ejemplares similares